Shunjie Xia
Hangzhou, 311121, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Activation of IGFBP4 via unconventional mechanism of miRNA attenuates metastasis of intrahepatic cholangiocarcinoma.
Journal: Hepatology international
Published: March 08, 2023
Efficacy of Laparoscopic Hepatectomy versus Open Surgery for Hepatocellular Carcinoma With Cirrhosis: A Meta-analysis of Case-Matched Studies.
Journal: Frontiers in oncology
Published: January 12, 2021
TAK1 Is a Novel Target in Hepatocellular Carcinoma and Contributes to Sorafenib Resistance.
Journal: Cellular and molecular gastroenterology and hepatology
Published: November 03, 2020
N6-methyladenosine-modified CircRNA-SORE sustains sorafenib resistance in hepatocellular carcinoma by regulating β-catenin signaling.
Journal: Molecular cancer
Published: May 19, 2020
UBQLN1 mediates sorafenib resistance through regulating mitochondrial biogenesis and ROS homeostasis by targeting PGC1β in hepatocellular carcinoma.
Journal: Signal transduction and targeted therapy
Published: May 10, 2020
LXR activation potentiates sorafenib sensitivity in HCC by activating microRNA-378a transcription.
Journal: Theranostics
Published: February 21, 2020
The microenvironmental and metabolic aspects of sorafenib resistance in hepatocellular carcinoma.
Journal: EBioMedicine
Published: October 30, 2019
miR-486-3p mediates hepatocellular carcinoma sorafenib resistance by targeting FGFR4 and EGFR.
Journal: Cell death & disease
Published: October 25, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026